China Pharma Holdings (CPHI) Goodwill & Intangibles (2010 - 2026)

China Pharma Holdings has reported Goodwill & Intangibles for 17 years, with the latest figure at $38.3 million in Q1 2026.

• For the quarter ending Q1 2026, Goodwill & Intangibles rose 483.42% year-over-year to $38.3 million; the trailing twelve-month figure through Mar 2026 stood at $38.3 million (up 483.42% YoY), and the FY2025 full-year result was $24.1 million, up 105.69% from the prior year.
• Goodwill & Intangibles for Q1 2026 stood at $38.3 million, up from $24.1 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $38.3 million in Q1 2026, with the low at $106788.0 in Q3 2022.
• Historically, Goodwill & Intangibles has averaged $7.0 million across 5 years, with a median of $4.4 million in 2024.
• Annual changes were most pronounced in 2022 — Goodwill & Intangibles plunged 31.02% — and 2023, when it jumped 1437.96%.
• China Pharma Holdings' Goodwill & Intangibles stood at $1.8 million in 2022, then surged by 80.1% to $3.3 million in 2023, then jumped by 259.62% to $11.7 million in 2024, then jumped by 105.69% to $24.1 million in 2025, then surged by 59.18% to $38.3 million in 2026.
• The last three Goodwill & Intangibles figures came in at $38.3 million (Q1 2026), $24.1 million (Q4 2025), and $8.4 million (Q3 2025), per Business Quant data.